Does APREMILAST Cause Basal cell carcinoma? 208 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 208 reports of Basal cell carcinoma have been filed in association with APREMILAST (Otezla). This represents 0.2% of all adverse event reports for APREMILAST.
208
Reports of Basal cell carcinoma with APREMILAST
0.2%
of all APREMILAST reports
1
Deaths
159
Hospitalizations
How Dangerous Is Basal cell carcinoma From APREMILAST?
Of the 208 reports, 1 (0.5%) resulted in death, 159 (76.4%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 208 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which APREMILAST Alternatives Have Lower Basal cell carcinoma Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA